Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: Impact of dietary n-3 fatty acids

Diabetologia

Volumn 49, Issue 8, 2006, Pages 1937-1945

  Levy, E ^a,d   Spahis, S ^a   Ziv, E ^b   Marette, A ^c   Elchebly, M ^d   Lambert, M ^d   Delvin, E ^d  

^a UNIVERSITY OF MONTREAL   (Canada)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Apo B 48; DGAT; Gerbil; Intestinal fat absorption; MGAT; Microsomal triglyceride transfer protein; n 3 fatty acids; Psammomys obesus; TG rich lipoprotein

Indexed keywords

ACYLGLYCEROL PALMITOYLTRANSFERASE; APOLIPOPROTEIN B48; CARBON 14; CHOLESTEROL ESTER; DIACYLGLYCEROL ACYLTRANSFERASE; FISH OIL; INSULIN; LIPID; LIPOPROTEIN; METHIONINE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; OLEIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; PROTEASOME; SULFUR 35; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; BODY WEIGHT; CALORIC INTAKE; DIETARY INTAKE; DOWN REGULATION; DYSLIPIDEMIA; ENZYME ACTIVITY; ESTERIFICATION; EXPLANT; FEEDING; GENE EXPRESSION; GERBIL; HYPERGLYCEMIA; HYPERINSULINEMIA; INCUBATION TIME; INSULIN RESISTANCE; INTESTINE CELL; JEJUNUM; LIPID ANALYSIS; LIPID TRANSPORT; LIPOGENESIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN SYNTHESIS; PSAMMOMYS OBESUS;

EID: 33745802004     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0315-3     Document Type: Article

References (52)

1. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F (1998) Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97:1029-1036
2. Castelli WP (1992) Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 70:3H-9H
3. Assmann G, Schulte H, Cullen P (1997) New and classical risk factors - the Munster heart study (PROCAM). Eur J Med Res 2:237-242
4. Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11:2-14
5. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219
6. Ericsson CG, Hamsten A, Nilsson J, Grip L, Svane B, de Faire U (1996) Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male post-infarction patients. Lancet 347:849-853
7. Miller M, Seidler A, Moalemi A, Pearson TA (1998) Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J Am Coll Cardiol 31:1252-1257
8. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A (1994) Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106:83-97
9. Patsch JR, Miesenbock G, Hopferwieser T et al (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12:1336-1345
10. Groot PH, van Stiphout WA, Krauss XH et al (1991) Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11:653-662
11. Garcia MJ, McNamara PM, Gordon T, Kannel WB (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23:105-111
12. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234
13. Gotto AM Jr (1998) Triglyceride: the forgotten risk factor. Circulation 97:1027-1028
14. Marsh JB (2003) Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans. Nutr Rev 61:363-375
15. Taskinen MR (2001) Pathogenesis of dyslipidemia in type 2 diabetes. Exp Clin Endocrinol Diabetes 109(Suppl 2):S180-S188
16. Syvanne M, Hilden H, Taskinen MR (1994) Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 35:15-26
17. Haidari M, Leung N, Mahbub F et al (2002) Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J Biol Chem 277:31646-31655
18. Zoltowska M, Ziv E, Delvin E et al (2003) Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes. Diabetes 52:2539-2545
19. Kromhout D, Bosschieter EB, de Lezenne CC (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312:1205-1209
20. von Schacky C (2000) n-3 fatty acids and the prevention of coronary atherosclerosis. Am J Clin Nutr 71:224S-227S
21. Harris WS (1989) Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30:785-807
22. Sirtori CR, Crepaldi G, Manzato E et al (1998) One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis 137:419-427
23. Yosefy C, Viskoper JR, Laszt A et al (1999) The effect of fish oil on hypertension, plasma lipids and hemostasis in hypertensive, obese, dyslipidemic patients with and without diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 61:83-87
24. Glauber H, Wallace P, Griver K, Brechtel G (1988) Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108:663-668
25. Kasim SE, Stern B, Khilnani S, McLin P, Baciorowski S, Jen KL (1988) Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients. J Clin Endocrinol Metab 67:1-5
26. Zoltowska M, Ziv E, Delvin E et al (2001) Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia. Atherosclerosis 157:85-96
27. Levy E, Thibault L, Menard D (1992) Intestinal lipids and lipoproteins in the human fetus: modulation by epidermal growth factor. J Lipid Res 33:1607-1617
28. Levy E, Menard D, Delvin E et al (2001) The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem 276:39679-39684
29. Levy E, Marcel Y, Deckelbaum RJ et al (1987) Intestinal apoB synthesis, lipids, and lipoproteins in chylomicron retention disease. J Lipid Res 28:1263-1274
30. Levy E, Sinnett D, Thibault L, Nguyen TD, Delvin E, Menard D (1996) Insulin modulation of newly synthesized apolipoproteins B-100 and B-48 in human fetal intestine: gene expression and mRNA editing are not involved. FEBS Lett 393:253-258
31. Levy E, Stan S, Delvin E et al (2002) Localization of microsomal triglyceride transfer protein in the Golgi: possible role in the assembly of chylomicrons. J Biol Chem 277:16470-16477
32. Slight I, Bendayan M, Malo C, Delvin E, Lambert M, Levy E (2004) Identification of microsomal triglyceride transfer protein in intestinal brush-border membrane. Exp Cell Res 300:11-22
33. Coleman RA (1992) Diacylglycerol acyltransferase and monoacylglycerol acyltransferase from liver and intestine. Methods Enzymol 209:98-104
34. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
35. Kalman R, Adler JH, Lazarovici G, Bar-On H, Ziv E (1993) The efficiency of sand rat metabolism is responsible for development of obesity and diabetes. J Basic Clin Physiol Pharmacol 4:57-68
36. Borkman M, Chisholm DJ, Furler SM et al (1989) Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38:1314-1319
37. Vessby B (1989) n-3 fatty acids and blood glucose control in diabetes mellitus. J Intern Med 731(Suppl):207-210
38. Westerveld HT, de Graaf JC, van Breugel HH et al (1993) Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein (a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM. Diabetes Care 16:683-688
39. Axelrod L, Camuso J, Williams E, Kleinman K, Briones E, Schoenfeld D (1994) Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study. Diabetes Care 17:37-44
40. Luo J, Rizkalla SW, Vidal H et al (1998) Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study. Diabetes Care 21:717-724
41. Yu KC, Cooper AD (2001) Postprandial lipoproteins and atherosclerosis. Front Biosci 6:D332-D354
42. McNamara JR, Shah PK, Nakajima K et al (2001) Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 154:229-236
43. Karpe F, Boquist S, Tang R, Bond GM, de Faire U, Hamsten A (2001) Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J Lipid Res 42:17-21
44. Doi H, Kugiyama K, Oka H et al (2000) Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 102:670-676
45. Boquist S, Ruotolo G, Tang R et al (1999) Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 100:723-728
46. Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF (2001) Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med 11:170-176
47. Carpentier A, Taghibiglou C, Leung N et al (2002) Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277:28795-28802
48. Lewis GF, Naples M, Uffelman K, Leung N, Szeto L, Adeli K (2004) Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters. Endocrinology 145:5006-5012
49. Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R (1984) Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 74:82-89
50. Harris WS (1997) n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65:1645S-1654S
51. Wetterau JR, Aggerbeck LP, Bouma ME et al (1992) Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258:999-1001
52. Lehner R, Kuksis A (1996) Biosynthesis of triacylglycerols. Prog Lipid Res 35:169-201